Name: PLSE Balance Sheet - Pulse Biosciences Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

PLSE - Pulse Biosciences, Inc.

USD | NASDAQ | Healthcare

PLSE Balance Sheet - Pulse Biosciences Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014
Cash And Short Term Investments
Cash And Equivalents	80.7	118.0	44.4	61.1	28.6	12.5	6.9	51.1	3.4	2.1	3.6	7.0
Restricted Cash	-	-	-	-	-	-	-	-	-	-	-	-
Short Term Investments	-	-	-	-	-	8.0	18.5	8.5	34.7	14.3	-	-
Cash And Short Term Investments	80.7	118.0	44.4	61.1	28.6	20.5	25.4	59.6	38.1	16.4	3.6	7.0
Receivables
Accounts Receivable	0.3	0.0	-	0.0	0.1	-	-	-	-	-	-	-
Current Assets
Inventory	0.1	0.0	-	0.0	5.8	-	-	-	-	-	-	-
Prepaid Expenses	2.3	1.4
Non-Current Assets
Property, Plant & Equipment Gross	5.4	5.1	5.0	4.9	4.9	4.4	4.1	3.2	3.1	0.5	0.4	-
Accumulated Depreciation
Current Liabilities
Accounts Payable	2.8	1.7	1.8	1.6	2.9	1.7	2.0	1.3	0.8	0.3	0.3	-
Short Term Debt	-	-
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	6.0
Common Equity
Common Stock	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-
Additional Paid In Capital	-	-
Supplementary Data
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-
Net debt	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Cash And Short Term Investments
Cash And Equivalents	68.3	80.7	95.2	106.3	119.3	118.0	79.0	26.2	34.9	44.4	50.4	58.7	54.1	61.1	69.2

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Current Assets
Inventory	0.2	0.1	0.1	0.1	0.0	0.0	-	-	-	-	-	-	-	-	0.8	7.9	7.5	5.8	4.3	2.7	1.1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	2.4	2.3	1.9	1.8	1.6	1.4	1.4	1.0	1.0	1.0	1.2	1.2	0.8	1.0	1.2	1.1	2.0	1.0
Other Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	71.1	83.4	97.2	108.2	120.9	119.4	80.4	27.2	35.8	45.3	51.6	60.0	54.9	62.1	71.2	23.7

Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	5.5	6.0	6.4	6.8	7.2	7.5	7.2	7.5	7.8	8.1	8.4	8.6	8.9	9.1	9.4	9.6
Deferred Revenue Non-Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Tax Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	15.3	13.9	16.1	15.8	14.9	17.6	13.9	13.5	12.9	14.8	13.8	14.3	80.9	80.1	81.4	17.2

Supplementary Data
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Working Capital	61.3	75.5	87.5	99.2	113.1	109.4	73.7	21.3	30.8	38.6	46.2	54.3	48.0	56.2	64.2	16.2	13.3	38.6
Book Value	66.3	80.7	92.7	104.5	118.5	114.9	79.1	27.0	36.3	44.4	52.1	60.5	(10.7)	(2.2)	6.2	23.4	20.8	44.4
Tangible Book Value	63.1	77.3	89.2	100.8	114.6	110.9	75.0	22.6	31.8	39.7	47.3	55.5	(15.8)	(7.6)	0.7	17.7	15.0